Latest news
Eli Lilly opens narrow early-access door to its experimental obesity drug - Benefits and Pensions MonitorBenefits and Pensions Monitor · Wed, 05 Aug 2026 11:46:23 GMTWho Is Eligible To Get Eli Lilly's Experimental Weight Loss Drug Before Approval? Criteria Explained - Health and MeHealth and Me · Wed, 05 Aug 2026 01:30:00 GMTEli Lilly to Offer Experimental GLP-1 Retatrutide for Compassionate Use — Who Qualifies? - everydayhealth.comeverydayhealth.com · Wed, 05 Aug 2026 00:21:28 GMTAccess expanding for experimental weight loss drug - CBS NewsCBS News · Tue, 04 Aug 2026 11:16:00 GMTEli Lilly to offer limited early access to experimental weight-loss drug - medwatch.commedwatch.com · Tue, 04 Aug 2026 07:48:00 GMT